Company / PP&E per Share
Neurocrine Biosciences PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.90
FY2025
5-year range
$0.62 / $0.90
FY2021-FY2025
Trend
+8.0%
vs FY2024
Sector context
#47 of 193
Health Care
What the data says
Neurocrine Biosciences's pp&e per share of $0.90 is higher than 76% of companies in the Health Care sector (FY2025). PP&E per Share has increased for 3 consecutive years, from $0.62 in FY2022 to $0.90 in FY2025.
Based on SEC 10-K filings.
0.90 in FY2025 with a 5-year CAGR of +13.3%. Top quartile in the Health Care sector.
Improved from $0.73 to $0.90 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +13.5%
- 5-Year CAGR
- +13.3%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 193This company $0.90 Sector average $18.71
▼
-95.2% below sector average
Key checks
Key Insights
- Neurocrine Biosciences's pp&e per share has grown for 3 consecutive years.
- In FY2025, pp&e per share increased 8.0% year-over-year.
- Ranks #47 out of 193 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.90 | +8.0% |
| FY2024 | $0.84 | +14.1% |
| FY2023 | $0.73 | +18.8% |
| FY2022 | $0.62 | -1.5% |
| FY2021 | $0.63 | +29.7% |
| FY2020 | $0.48 | +4.7% |
| FY2019 | $0.46 | +21.0% |
| FY2018 | $0.38 | +206.5% |
| FY2017 | $0.12 | +71.2% |
| FY2016 | $0.07 | +62.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026